创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

column
Research Advances of Indoleamine 2, 3-Dioxygenase-1 and Its Inhibitors
YE Ke, QIU Yatao, ZHANG Wanheng, JIANG Sheng
2019, 43(7): 483-503.
Abstract PDF
Recent Advances in Research on Small-molecule TBK1 Inhibitors
CHANG Yu, DING Ke
2019, 43(7): 504-516.
Abstract PDF
Research Advances in the Protein Tyrosine Phosphatase SHP2 and Its Inhibitors
KONG Jiao, LONG Yaqiu
2019, 43(7): 517-526.
Abstract PDF
Advances on Role of Exosomes in Pathogenesis and Progression of Diabetes Mellitus
BIAN Huan, WANG Ying, XU Hanmei
2019, 43(7): 527-534.
Abstract PDF
Pharmacokinetic-Pharmacodynamic Model for Cardiac Safety Assessment of Antitumor Drugs
YUAN Yi, HE Hua, LIU Xiaoquan
2019, 43(7): 535-543.
Abstract PDF
New Anti-cancer Strategies to Reverse the Abnormal pH Gradient of Tumor Microenvironment
WANG Yiyang, LIU Yang, YUAN Shengtao, SUN Li
2019, 43(7): 544-550.
Abstract PDF
A Report of New Drugs Research and Development in 2018—Part Ⅰ: New Drugs & Biologics (Ⅲ)
Graul A I, Pina P, Cruces E, Stringer M
2019, 43(7): 551-557.
Abstract PDF
An Overview of New Drugs Approved in the US, EU and Japan in June 2019
SUN Yousong
2019, 43(7): 558-560, 附页2.
Abstract PDF